Seehra Jasbir

Seehra Jasbir is listed in filings as CHIEF EXECUTIVE OFFICER at Keros Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 6, 2026, including sale activity. Recent filings connect the profile to Keros Therapeutics, Inc. (KROS). The current snapshot covers public activity from Apr 7, 2025 to Apr 6, 2026. Reported amounts are shown as $16.5K to $1.6M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.